Skip to search formSkip to main contentSkip to account menu

pan FGFR Inhibitor ARQ 087

Known as: ARQ 087 
An orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. FGFR inhibitor ARQ 087 binds… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
ENTREVISTA: ARQ. MAG. YENNIA ESPERANZA SIERRA REPORTAJE CAMARGO POR LAURA CRISTINA PACHON 
2015
2015
2545 Background: ARQ 087 is a novel, orally bioavailable, ATP-competitive inhibitor of multiple kinases, including FGFR1-3. It… 
2015
2015
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA ARQ087 is a non ATP-competitive tyrosine kinase… 
2015
2015
Background: Early biomarker development is vital in the current clinical landscape of targeted oncology therapies. Biomarkers… 
2012
2012
Aim: To analyze the socioeconomic and behavioral factors associated with the presence of dental plaque on the occlusal surface of… 
2012
2012
Giris ve Amac Dunya Saglik Orgutu diyabetes mellitusu yeni bin yilin en onemli halk sagligi sorunlari arasinda kabul etmektedir… 
Review
2008
Review
2008
This article critically reviews the role of evidence-based medicine and its guidelines, from their logistic preparation to their… 
2004
2004
1986
1986
Arq Keora and Arq Gulab carry medicinal properties and they are widely used in the Unani and Ayurvedic systems of medicines for…